Abstract:Understanding the function of genes and their regulation in tissue homeostasis and disease requires knowing the cellular context in which genes are expressed in tissues across the body. Single cell genomics allows the generation of detailed cellular atlases in human tissues, but most efforts are focused on single tissue types. Here, we establish a framework for profiling multiple tissues across the human body at single-cell resolution using single nucleus RNA-Seq (snRNA-seq), and apply it to 8 diverse, archived, frozen tissue types (three donors per tissue). We apply four snRNA-seq methods to each of 25 samples from 16 donors, generating a cross-tissue atlas of 209,126 nuclei profiles, and benchmark them vs . scRNA-seq of comparable fresh tissues. We use a conditional variational autoencoder (cVAE) to integrate an atlas across tissues, donors, and laboratory methods. We highlight shared and tissue-specific features of tissue-resident immune cells, identifying tissue-restricted and non-restricted resident myeloid populations. These include a cross-tissue conserved dichotomy between LYVE1- and HLA class II-expressing macrophages, and the broad presence of LAM-like macrophages across healthy tissues that is also observed in disease. For rare, monogenic muscle diseases, we identify cell types that likely underlie the neuromuscular, metabolic, and immune components of these diseases, and biological processes involved in their pathology. For common complex diseases and traits analyzed by GWAS, we identify the cell types and gene modules that potentially underlie disease mechanisms. The experimental and analytical frameworks we describe will enable the generation of large-scale studies of how cellular and molecular processes vary across individuals and populations. ### Competing Interest Statement A.R. is a co-founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas, and was an SAB member of ThermoFisher Scientific, Syros Pharmaceuticals, Neogene Therapeutics and Asimov until 31 July 2020. Since 1 August 2020, A.R. has been an employee of Genentech. G.G. was partially funded by the Paul C. Zamecnik Chair in Oncology at the Massachusetts General Hospital Cancer Center. G.G. receives research funds from IBM and Pharmacyclics, and is an inventor on patent applications related to MuTect, ABSOLUTE, MutSig, MSMuTect, MSMutSig, MSIDetect, POLYSOLVER and TensorQTL. G.G. is a founder, consultant, and holds privately-held equity in Scorpion Therapeutics. F.A. is an inventor on a patent application related to TensorQTL. E.D. is an employee of Bristol Myers Squibb. O.R.R. is an employee of Genentech. O.R.R. and A.R. are co-inventors on patent applications filed at the Broad related to single cell genomics.

Inferring relevant cell types for complex traits using single-cell gene expression

Identifying disease-critical cell types and cellular processes by integrating single-cell RNA-sequencing and human genetics

Disentangling associations between complex traits and cell types with

Polygenic Regression Uncovers Trait-Relevant Cellular Contexts Through Pathway Activation Transformation of Single-Cell RNA Sequencing Data

Polygenic enrichment distinguishes disease associations of individual cells in single-cell RNA-seq data

Leveraging single-cell ATAC-seq and RNA-seq to identify disease-critical fetal and adult brain cell types

Differential expression and co-expression reveal cell types relevant to rare disease phenotypes

Deconvolution of polygenic risk score in single cells unravels cellular and molecular heterogeneity of complex human diseases

Cell type-specific expression analysis to identify putative cellular mechanisms for neurogenetic disorders.

A computational method for direct imputation of cell type-specific expression profiles and cellular compositions from bulk-tissue RNA-Seq in brain disorders

Single-nucleus Cross-Tissue Molecular Reference Maps to Decipher Disease Gene Function

Cell type discovery using single-cell transcriptomics: implications for ontological representation

Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types

Inferring causal cell types of human diseases and risk variants from candidate regulatory elements

scGRNom: a computational pipeline of integrative multi-omics analyses for predicting cell-type disease genes and regulatory networks

Identifying genetic variants that influence the abundance of cell states in single-cell data

Regulatory landscape enrichment analysis (RLEA): a computational toolkit for non-coding variant enrichment and cell type prioritization

An analytical method for the identification of cell type-specific disease gene modules

Population-scale single-cell RNA-seq profiling across dopaminergic neuron differentiation

CellMapper: Rapid and Accurate Inference of Gene Expression in Difficult-to-isolate Cell Types

Single-cell genomics and regulatory networks for 388 human brains